Shirakawa R
From Bioblast
Revision as of 09:55, 18 August 2016 by Erhart Verena (talk | contribs) (Created page with "{{Person |lastname=Shirakawa |firstname=Ryosuke |institution=Hokkaido University Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine |addres...")
Name | Shirakawa Ryosuke, |
---|---|
Institution | Hokkaido University
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine |
Address | Kita-14 Nishi-7, Kita-Ku, 060-8638 |
City | Sapporo |
State/Province | |
Country | Japan |
ryo56713@gmail.com | |
Weblink | |
O2k-Network Lab | JP Sapporo Yokota T |
Labels:
Publications
Published | Reference | |
---|---|---|
Shirakawa 2023 Sci Rep | 2023 | Shirakawa R, Nakajima T, Yoshimura A, Kawahara Y, Orito C, Yamane M, Handa H, Takada S, Furihata T, Fukushima A, Ishimori N, Nakagawa M, Yokota I, Sabe H, Hashino S, Kinugawa S, Yokota T (2023) Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults. https://doi.org/10.1038/s41598-023-32549-w |
Nambu 2021 Cardiovasc Res | 2021 | Nambu H, Takada S, Maekawa S, Matsumoto J, Kakutani N, Furihata T, Shirakawa R, Katayama T, Nakajima T, Yamanashi K, Obata Y, Nakano I, Tsuda M, Saito A, Fukushima A, Yokota T, Nio-Kobayashi J, Yasui H, Higashikawa K, Kuge Y, Anzai T, Sabe H, Kinugawa S (2021) Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance. Cardiovasc Res 117:805-19. |
Furihata 2021 BMC Pharmacol Toxicol | 2021 | Furihata T, Maekawa S, Takada S, Kakutani N, Nambu H, Shirakawa R, Yokota T, Kinugawa S (2021) Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice. BMC Pharmacol Toxicol 22:27. |
Shirakawa 2019 Sci Rep | 2019 | Shirakawa R, Yokota T, Nakajima T, Takada S, Yamane M, Furihata T, Maekawa S, Nambu H, Katayama T, Fukushima A, Saito A, Ishimori N, Dela F, Kinugawa S, Anzai T (2019) Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients. Sci Rep 9:14709. |
Nambu 2019 Eur J Pharmacol | 2019 | Nambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Nakano I, Furihata T, Katayama T, Yamanashi K, Obata Y, Saito A, Yokota T, Kinugawa S (2019) Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure. Eur J Pharmacol 866:172810. |
Nakajima 2019 Sci Rep | 2019 | Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, Wakasa S, Ooka T, Takada S, Shirakawa R, Katayama T, Furihata T, Fukushima A, Matsuoka R, Nishihara H, Dela F, Nakanishi K, Matsui Y, Kinugawa S (2019) Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis. Sci Rep 9:3535. |
Abstracts
Published | Reference | |
---|---|---|
Nakajima 2017 Europ Heart J | 2017 | Mitochondrial dysfunction in epicardial adipose tissue; possible role in progression of coronary artery disease. |